By Dr Jonathan Brett

Journal articles

Zhou F; Khushi M; Brett J; Uddin S, 2024, 'Graph neural network-based subgraph analysis for predicting adverse drug events', Computers in Biology and Medicine, 183, http://dx.doi.org/10.1016/j.compbiomed.2024.109282

Carroll A; Bayes A; Montebello M; Brett J; Arunogiri S; Saunders JB; Loo CK, 2024, 'Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand', Australian and New Zealand Journal of Psychiatry, 58, pp. 831 - 838, http://dx.doi.org/10.1177/00048674241242315

Carland JE; Carland DJ; Brett J; Stocker SL; Roberts DM; Day RO; Laba TL, 2024, 'Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review', British Journal of Clinical Pharmacology, 90, pp. 2038 - 2066, http://dx.doi.org/10.1111/bcp.16164

Varney B; Brett J; Zoega H; Gillies MB; Powell M; Bateman BT; Shand AW; Pearson SA; Havard A, 2024, 'Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis^†', Anaesthesia, 79, pp. 967 - 977, http://dx.doi.org/10.1111/anae.16307

Page R; Jauncey M; Brett J; Wood W; Roxburgh A, 2024, 'The role of on-site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need', Drug and Alcohol Review, 43, pp. 1592 - 1596, http://dx.doi.org/10.1111/dar.13909

Harris O; Siefried KJ; Chiew A; Jamshidi N; Chung DT; Moore N; Nic Ionmhain U; Roberts DM; Ezard N; Brett J, 2024, 'Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021', EMA - Emergency Medicine Australasia, 36, pp. 604 - 608, http://dx.doi.org/10.1111/1742-6723.14402

Camacho X; Schaffer AL; Brett J; Pratt N; Buckley NA; Henry D; Pearson SA, 2024, 'Quality use of publicly subsidised tapentadol in Australia: a population-based analysis', Internal Medicine Journal, 54, pp. 941 - 950, http://dx.doi.org/10.1111/imj.16335

Schulz M; Coleshill MJ; Day RO; Wright DFB; Brett J; Briggs NE; Aung E, 2024, 'Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing', British Journal of Clinical Pharmacology, 90, pp. 1322 - 1332, http://dx.doi.org/10.1111/bcp.16016

Acheson LS; Clay S; McKetin R; Lintzeris N; Dunlop A; Brett J; Christmass M; Rodgers C; Shoptaw S; Farrell M; Ezard N; Siefried KJ, 2024, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104383

Koch FC; Olivier J; Brett J; Buckley NA; Gisev N; Pearson S; Daniels B, 2024, 'The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis', Medical Journal of Australia, 220, pp. 315 - 322, http://dx.doi.org/10.5694/mja2.52257

Acheson LS; Gordon C; Mcketin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried KJ, 2024, 'Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study', European Addiction Research, 30, pp. 121 - 125, http://dx.doi.org/10.1159/000536328

Solaja I; Haldane K; Mason N; Weiss B; Xu X; Xu M; Nikolin S; Jayasena T; Millard M; Brett J; Bayes A; Loo CK; Martin DM, 2024, 'Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality', Neuroscience and Biobehavioral Reviews, 158, http://dx.doi.org/10.1016/j.neubiorev.2024.105570

Cairns R; Noghrehchi F; Raubenheimer JE; Chitty KM; Isbister GK; Chiew AL; Brett J; Dawson AH; Brown JA; Buckley NA, 2024, 'Poisoning and envenomation linkage to evaluate outcomes and clinical variation in Australia (PAVLOVA): a longitudinal data-linkage cohort of acute poisonings, envenomations, and adverse drug reactions in New South Wales, Australia, 2011–2020', Clinical Toxicology, 62, pp. 615 - 624, http://dx.doi.org/10.1080/15563650.2024.2398119

Wardle F; Piatkowski T; Clifford S; Peacock A; Dietze P; Lim M; Douglass C; Hill P; Moore S; Miller M; Brett J; Wright CJC, 2024, 'Safe beats down under: investigating the support of drug checking at a regional festival in the Northern Territory, Australia', Drugs: Education, Prevention and Policy, http://dx.doi.org/10.1080/09687637.2024.2330938

Wilkes R; Roberts DM; Liknaitzky P; Brett J, 2024, 'The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics', Clinical Toxicology, 62, pp. 242 - 247, http://dx.doi.org/10.1080/15563650.2024.2346612

Freestone J; Ezard N; Bourne A; Brett J; Roberts DM; Hammoud M; Nedanoski A; Prestage G; Siefried KJ, 2023, 'Understandings, attitudes, practices and responses to GHB overdose among GHB consumers', Harm Reduction Journal, 20, pp. 121, http://dx.doi.org/10.1186/s12954-023-00857-z

Brett J; Gillies MB; Buckley NA; Pearson SA; Zoega H, 2023, 'Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?', British Journal of Clinical Pharmacology, 89, pp. 3411 - 3420, http://dx.doi.org/10.1111/bcp.15821

Yang JJ; Brett J; Sordo A; Reuter SE; Stocker SL; Day RO; Roberts DM; Carland JE, 2023, 'The Influence of a Therapeutic Drug Monitoring Service on Vancomycin-Associated Nephrotoxicity', Journal of Clinical Pharmacology, 64, pp. 19 - 29, http://dx.doi.org/10.1002/jcph.2363

Brett J; Bahceci D; Lipworth W; Liknaitzky P; Day RO; Rodgers A, 2023, 'Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applications', Internal Medicine Journal, 53, pp. 1284 - 1287, http://dx.doi.org/10.1111/imj.16159

Bruno C; Zoega H; Gillies MB; Havard A; Coghill D; Pearson SA; Brett J, 2023, 'Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis', Australian and New Zealand Journal of Psychiatry, 57, pp. 1073 - 1076, http://dx.doi.org/10.1177/00048674231170556

Carland JE; Stacy AE; Schaffer AL; Day RO; Brett J; Reuter SE; Stocker SL, 2023, 'Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin', British Journal of Clinical Pharmacology, 89, pp. 1896 - 1902, http://dx.doi.org/10.1111/bcp.15668

Bruno C; Havard A; Gillies MB; Coghill D; Brett J; Guastella AJ; Pearson SA; Zoega H, 2023, 'Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)', Australian and New Zealand Journal of Psychiatry, 57, pp. 675 - 685, http://dx.doi.org/10.1177/00048674221114782

Brett J; Knock E; Korthuis PT; Liknaitzky P; Murnane KS; Nicholas CR; Patterson JC; Stauffer CS, 2023, 'Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder', Frontiers in Psychiatry, 14, http://dx.doi.org/10.3389/fpsyt.2023.1123424

Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J, 2023, 'Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review', Psychopharmacology, 240, pp. 127 - 135, http://dx.doi.org/10.1007/s00213-022-06283-6

Freeman G; Siefried KJ; Roberts DM; Rodgers C; Nic Ionmhain U; Ramanathan J; Ezard N; Brett J, 2023, 'Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series', Drug and Alcohol Review, 42, pp. 27 - 32, http://dx.doi.org/10.1111/dar.13556

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, 241, pp. 109692, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692

Chiew AL; Raubenheimer JE; Berling I; Buckley NA; Becker T; Chan B; Brett J, 2022, 'Just ‘nanging’ around – harmful nitrous oxide use: a retrospective case series and review of Internet searches, social media posts and the coroner's database', Internal Medicine Journal, 52, pp. 1724 - 1732, http://dx.doi.org/10.1111/imj.15391

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', PLoS ONE, 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371

Page R; Healey A; Siefried KJ; Harrod ME; Franklin E; Peacock A; Barratt MJ; Brett J; Peacock A, 2022, 'Barriers to help-seeking among music festival attendees in New South Wales, Australia', Drug and Alcohol Review, 41, pp. 1322 - 1330, http://dx.doi.org/10.1111/dar.13479

Camacho X; Schaffer A; Buckley N; Pratt N; Brett J; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilisation of sustained-release tapentadol in Australia.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1978

Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N, 2022, 'Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with ‘take-home naloxone’ in emergency departments', EMA - Emergency Medicine Australasia, 34, pp. 509 - 518, http://dx.doi.org/10.1111/1742-6723.13925

Varney B; Zoega H; Gillies MB; Brett J; Pearson SA; Havard A, 2022, 'Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies', British Journal of Clinical Pharmacology, 88, pp. 1298 - 1320, http://dx.doi.org/10.1111/bcp.15074

Healey A; Siefried KJ; Harrod ME; Franklin E; Peacock A; Barratt MJ; Brett J, 2022, 'Correlates of higher-risk drug-related behaviours at music festivals in New South Wales, Australia', Drug and Alcohol Review, 41, pp. 320 - 329, http://dx.doi.org/10.1111/dar.13404

Murnion B; Schaffer A; Cairns R; Brett J, 2022, 'Gabapentinoids: repeating mistakes of the past?', Addiction, 117, pp. 2969 - 2971, http://dx.doi.org/10.1111/add.15970

Brett J; Siefried KJ; Healey A; Harrod ME; Franklin E; Barratt MJ; Masters J; Nguyen L; Adiraju S; Gerber C, 2022, 'Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019–2020', Clinical Toxicology, 60, pp. 440 - 445, http://dx.doi.org/10.1080/15563650.2021.1979233

Schaffer AL; Chia J; Brett J; Pearson S; Falster MO, 2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836, http://dx.doi.org/10.1002/phar.2735

Busingye D; Daniels B; Brett J; Pollack A; Belcher J; Chidwick K; Blogg S, 2021, 'Patterns of real-world opioid prescribing in Australian general practice (2013-18)', Australian Journal of Primary Health, 27, pp. 416 - 424, http://dx.doi.org/10.1071/PY20270

Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG, 2021, 'A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study (vol 109, pg 175, 2021)', CLINICAL PHARMACOLOGY & THERAPEUTICS, 110, pp. 1401 - 1401, http://dx.doi.org/10.1002/cpt.2353

Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL, 2021, 'Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients', Clinical Microbiology and Infection, 27, pp. 783.e7 - 783.e14, http://dx.doi.org/10.1016/j.cmi.2020.07.005

Braithwaite HE; Darley DR; Brett J; Day RO; Carland JE, 2021, 'Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review', Transplantation Reviews, 35, http://dx.doi.org/10.1016/j.trre.2021.100610

Brett J; Pearson SA; Daniels B; Wylie CE; Buckley NA, 2021, 'A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy', British Journal of Clinical Pharmacology, 87, pp. 1369 - 1377, http://dx.doi.org/10.1111/bcp.14527

Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG, 2021, 'A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study', Clinical Pharmacology and Therapeutics, 109, pp. 175 - 183, http://dx.doi.org/10.1002/cpt.2065

Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J, 2021, 'Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis', Clinical Pharmacology and Therapeutics, 109, pp. 212 - 221, http://dx.doi.org/10.1002/cpt.2113

Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S, 2021, 'Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study', BJGP Open, 5, pp. 1 - 10, http://dx.doi.org/10.3399/bjgpopen20X101120

Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA, 2020, 'A national study on prescribed medicine use in Australia on a typical day', Pharmacoepidemiology and Drug Safety, 29, pp. 1046 - 1053, http://dx.doi.org/10.1002/pds.5093

Black E; Govindasamy L; Auld R; McArdle K; Sharpe C; Dawson A; Vazquez S; Brett J; Friend C; Shaw V; Tyner S; McDonald C; Koop D; Tall G; Welsby D; Habig K; Madeddu D; Cretikos M, 2020, 'Toxicological analysis of serious drug-related harm among electronic dance music festival attendees in New South Wales, Australia: A consecutive case series', Drug and Alcohol Dependence, 213, http://dx.doi.org/10.1016/j.drugalcdep.2020.108070

Gisev N; Brett J; Peacock A, 2020, 'Extra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?', Addiction, 115, pp. 1203 - 1205, http://dx.doi.org/10.1111/add.14823

Zheng D; Brett J; Daniels B; Buckley NA; Pearson SA; Schaffer AL, 2020, 'Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014–2017)', Drug and Alcohol Review, 39, pp. 575 - 582, http://dx.doi.org/10.1111/dar.13086

Brett J; Anthony C; Day R, 2020, 'Off-label quetiapine prescribing in general hospital inpatients', Journal of Pharmacy Practice and Research, http://dx.doi.org/10.1002/jppr.1608

Stefani M; Roberts DM; Brett J, 2020, 'High-dose insulin euglycemic therapy to treat cardiomyopathy associated with massive venlafaxine overdose', Clinical Toxicology, 58, pp. 299 - 300, http://dx.doi.org/10.1080/15563650.2019.1638930

Back to profile page